Global Intravitreal Injectable Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Intravitreal Injectable market size was valued at US$ 14210 million in 2023. With growing demand in downstream market, the Intravitreal Injectable is forecast to a readjusted size of US$ 23380 million by 2030 with a CAGR of 7.4% during review period.
The research report highlights the growth potential of the global Intravitreal Injectable market. Intravitreal Injectable are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Intravitreal Injectable. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Intravitreal Injectable market.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
Key Features:
The report on Intravitreal Injectable market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Intravitreal Injectable market. It may include historical data, market segmentation by Drug (e.g., Anti-VEGF, Steroids), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Intravitreal Injectable market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Intravitreal Injectable market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Intravitreal Injectable industry. This include advancements in Intravitreal Injectable technology, Intravitreal Injectable new entrants, Intravitreal Injectable new investment, and other innovations that are shaping the future of Intravitreal Injectable.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Intravitreal Injectable market. It includes factors influencing customer ' purchasing decisions, preferences for Intravitreal Injectable product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Intravitreal Injectable market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Intravitreal Injectable market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Intravitreal Injectable market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Intravitreal Injectable industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Intravitreal Injectable market.
Market Segmentation:
Intravitreal Injectable market is split by Drug and by Disease. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Drug, and by Disease in terms of volume and value.
Segmentation by drug
What is the 10-year outlook for the global Intravitreal Injectable market?
What factors are driving Intravitreal Injectable market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravitreal Injectable market opportunities vary by end market size?
How does Intravitreal Injectable break out drug, disease?
According to our LPI (LP Information) latest study, the global Intravitreal Injectable market size was valued at US$ 14210 million in 2023. With growing demand in downstream market, the Intravitreal Injectable is forecast to a readjusted size of US$ 23380 million by 2030 with a CAGR of 7.4% during review period.
The research report highlights the growth potential of the global Intravitreal Injectable market. Intravitreal Injectable are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Intravitreal Injectable. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Intravitreal Injectable market.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
Key Features:
The report on Intravitreal Injectable market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Intravitreal Injectable market. It may include historical data, market segmentation by Drug (e.g., Anti-VEGF, Steroids), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Intravitreal Injectable market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Intravitreal Injectable market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Intravitreal Injectable industry. This include advancements in Intravitreal Injectable technology, Intravitreal Injectable new entrants, Intravitreal Injectable new investment, and other innovations that are shaping the future of Intravitreal Injectable.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Intravitreal Injectable market. It includes factors influencing customer ' purchasing decisions, preferences for Intravitreal Injectable product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Intravitreal Injectable market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Intravitreal Injectable market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Intravitreal Injectable market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Intravitreal Injectable industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Intravitreal Injectable market.
Market Segmentation:
Intravitreal Injectable market is split by Drug and by Disease. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Drug, and by Disease in terms of volume and value.
Segmentation by drug
- Anti-VEGF
- Steroids
- Others
- Macular Degeneration
- Macular Edema
- Uveitis
- Retinal Vein Occlusion
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Regeneron Pharmaceuticals (Eylea)
- Allergan
- EyePoint Pharmaceuticals
- Genentech
- Kanghong Pharmaceutical
What is the 10-year outlook for the global Intravitreal Injectable market?
What factors are driving Intravitreal Injectable market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravitreal Injectable market opportunities vary by end market size?
How does Intravitreal Injectable break out drug, disease?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravitreal Injectable Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Intravitreal Injectable by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Intravitreal Injectable by Country/Region, 2019, 2023 & 2030
2.2 Intravitreal Injectable Segment by Drug
2.2.1 Anti-VEGF
2.2.2 Steroids
2.2.3 Others
2.3 Intravitreal Injectable Sales by Drug
2.3.1 Global Intravitreal Injectable Sales Market Share by Drug (2019-2024)
2.3.2 Global Intravitreal Injectable Revenue and Market Share by Drug (2019-2024)
2.3.3 Global Intravitreal Injectable Sale Price by Drug (2019-2024)
2.4 Intravitreal Injectable Segment by Disease
2.4.1 Macular Degeneration
2.4.2 Macular Edema
2.4.3 Uveitis
2.4.4 Retinal Vein Occlusion
2.4.5 Others
2.5 Intravitreal Injectable Sales by Disease
2.5.1 Global Intravitreal Injectable Sale Market Share by Disease (2019-2024)
2.5.2 Global Intravitreal Injectable Revenue and Market Share by Disease (2019-2024)
2.5.3 Global Intravitreal Injectable Sale Price by Disease (2019-2024)
3 GLOBAL INTRAVITREAL INJECTABLE BY COMPANY
3.1 Global Intravitreal Injectable Breakdown Data by Company
3.1.1 Global Intravitreal Injectable Annual Sales by Company (2019-2024)
3.1.2 Global Intravitreal Injectable Sales Market Share by Company (2019-2024)
3.2 Global Intravitreal Injectable Annual Revenue by Company (2019-2024)
3.2.1 Global Intravitreal Injectable Revenue by Company (2019-2024)
3.2.2 Global Intravitreal Injectable Revenue Market Share by Company (2019-2024)
3.3 Global Intravitreal Injectable Sale Price by Company
3.4 Key Manufacturers Intravitreal Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravitreal Injectable Product Location Distribution
3.4.2 Players Intravitreal Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVITREAL INJECTABLE BY GEOGRAPHIC REGION
4.1 World Historic Intravitreal Injectable Market Size by Geographic Region (2019-2024)
4.1.1 Global Intravitreal Injectable Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Intravitreal Injectable Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Intravitreal Injectable Market Size by Country/Region (2019-2024)
4.2.1 Global Intravitreal Injectable Annual Sales by Country/Region (2019-2024)
4.2.2 Global Intravitreal Injectable Annual Revenue by Country/Region (2019-2024)
4.3 Americas Intravitreal Injectable Sales Growth
4.4 APAC Intravitreal Injectable Sales Growth
4.5 Europe Intravitreal Injectable Sales Growth
4.6 Middle East & Africa Intravitreal Injectable Sales Growth
5 AMERICAS
5.1 Americas Intravitreal Injectable Sales by Country
5.1.1 Americas Intravitreal Injectable Sales by Country (2019-2024)
5.1.2 Americas Intravitreal Injectable Revenue by Country (2019-2024)
5.2 Americas Intravitreal Injectable Sales by Drug
5.3 Americas Intravitreal Injectable Sales by Disease
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravitreal Injectable Sales by Region
6.1.1 APAC Intravitreal Injectable Sales by Region (2019-2024)
6.1.2 APAC Intravitreal Injectable Revenue by Region (2019-2024)
6.2 APAC Intravitreal Injectable Sales by Drug
6.3 APAC Intravitreal Injectable Sales by Disease
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravitreal Injectable by Country
7.1.1 Europe Intravitreal Injectable Sales by Country (2019-2024)
7.1.2 Europe Intravitreal Injectable Revenue by Country (2019-2024)
7.2 Europe Intravitreal Injectable Sales by Drug
7.3 Europe Intravitreal Injectable Sales by Disease
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravitreal Injectable by Country
8.1.1 Middle East & Africa Intravitreal Injectable Sales by Country (2019-2024)
8.1.2 Middle East & Africa Intravitreal Injectable Revenue by Country (2019-2024)
8.2 Middle East & Africa Intravitreal Injectable Sales by Drug
8.3 Middle East & Africa Intravitreal Injectable Sales by Disease
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravitreal Injectable
10.3 Manufacturing Process Analysis of Intravitreal Injectable
10.4 Industry Chain Structure of Intravitreal Injectable
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravitreal Injectable Distributors
11.3 Intravitreal Injectable Customer
12 WORLD FORECAST REVIEW FOR INTRAVITREAL INJECTABLE BY GEOGRAPHIC REGION
12.1 Global Intravitreal Injectable Market Size Forecast by Region
12.1.1 Global Intravitreal Injectable Forecast by Region (2025-2030)
12.1.2 Global Intravitreal Injectable Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravitreal Injectable Forecast by Drug
12.7 Global Intravitreal Injectable Forecast by Disease
13 KEY PLAYERS ANALYSIS
13.1 Regeneron Pharmaceuticals (Eylea)
13.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
13.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolios and Specifications
13.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview
13.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Intravitreal Injectable Product Portfolios and Specifications
13.2.3 Allergan Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 EyePoint Pharmaceuticals
13.3.1 EyePoint Pharmaceuticals Company Information
13.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolios and Specifications
13.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 EyePoint Pharmaceuticals Main Business Overview
13.3.5 EyePoint Pharmaceuticals Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Intravitreal Injectable Product Portfolios and Specifications
13.4.3 Genentech Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Kanghong Pharmaceutical
13.5.1 Kanghong Pharmaceutical Company Information
13.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolios and Specifications
13.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Kanghong Pharmaceutical Main Business Overview
13.5.5 Kanghong Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravitreal Injectable Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Intravitreal Injectable by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Intravitreal Injectable by Country/Region, 2019, 2023 & 2030
2.2 Intravitreal Injectable Segment by Drug
2.2.1 Anti-VEGF
2.2.2 Steroids
2.2.3 Others
2.3 Intravitreal Injectable Sales by Drug
2.3.1 Global Intravitreal Injectable Sales Market Share by Drug (2019-2024)
2.3.2 Global Intravitreal Injectable Revenue and Market Share by Drug (2019-2024)
2.3.3 Global Intravitreal Injectable Sale Price by Drug (2019-2024)
2.4 Intravitreal Injectable Segment by Disease
2.4.1 Macular Degeneration
2.4.2 Macular Edema
2.4.3 Uveitis
2.4.4 Retinal Vein Occlusion
2.4.5 Others
2.5 Intravitreal Injectable Sales by Disease
2.5.1 Global Intravitreal Injectable Sale Market Share by Disease (2019-2024)
2.5.2 Global Intravitreal Injectable Revenue and Market Share by Disease (2019-2024)
2.5.3 Global Intravitreal Injectable Sale Price by Disease (2019-2024)
3 GLOBAL INTRAVITREAL INJECTABLE BY COMPANY
3.1 Global Intravitreal Injectable Breakdown Data by Company
3.1.1 Global Intravitreal Injectable Annual Sales by Company (2019-2024)
3.1.2 Global Intravitreal Injectable Sales Market Share by Company (2019-2024)
3.2 Global Intravitreal Injectable Annual Revenue by Company (2019-2024)
3.2.1 Global Intravitreal Injectable Revenue by Company (2019-2024)
3.2.2 Global Intravitreal Injectable Revenue Market Share by Company (2019-2024)
3.3 Global Intravitreal Injectable Sale Price by Company
3.4 Key Manufacturers Intravitreal Injectable Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravitreal Injectable Product Location Distribution
3.4.2 Players Intravitreal Injectable Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVITREAL INJECTABLE BY GEOGRAPHIC REGION
4.1 World Historic Intravitreal Injectable Market Size by Geographic Region (2019-2024)
4.1.1 Global Intravitreal Injectable Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Intravitreal Injectable Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Intravitreal Injectable Market Size by Country/Region (2019-2024)
4.2.1 Global Intravitreal Injectable Annual Sales by Country/Region (2019-2024)
4.2.2 Global Intravitreal Injectable Annual Revenue by Country/Region (2019-2024)
4.3 Americas Intravitreal Injectable Sales Growth
4.4 APAC Intravitreal Injectable Sales Growth
4.5 Europe Intravitreal Injectable Sales Growth
4.6 Middle East & Africa Intravitreal Injectable Sales Growth
5 AMERICAS
5.1 Americas Intravitreal Injectable Sales by Country
5.1.1 Americas Intravitreal Injectable Sales by Country (2019-2024)
5.1.2 Americas Intravitreal Injectable Revenue by Country (2019-2024)
5.2 Americas Intravitreal Injectable Sales by Drug
5.3 Americas Intravitreal Injectable Sales by Disease
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravitreal Injectable Sales by Region
6.1.1 APAC Intravitreal Injectable Sales by Region (2019-2024)
6.1.2 APAC Intravitreal Injectable Revenue by Region (2019-2024)
6.2 APAC Intravitreal Injectable Sales by Drug
6.3 APAC Intravitreal Injectable Sales by Disease
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravitreal Injectable by Country
7.1.1 Europe Intravitreal Injectable Sales by Country (2019-2024)
7.1.2 Europe Intravitreal Injectable Revenue by Country (2019-2024)
7.2 Europe Intravitreal Injectable Sales by Drug
7.3 Europe Intravitreal Injectable Sales by Disease
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravitreal Injectable by Country
8.1.1 Middle East & Africa Intravitreal Injectable Sales by Country (2019-2024)
8.1.2 Middle East & Africa Intravitreal Injectable Revenue by Country (2019-2024)
8.2 Middle East & Africa Intravitreal Injectable Sales by Drug
8.3 Middle East & Africa Intravitreal Injectable Sales by Disease
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravitreal Injectable
10.3 Manufacturing Process Analysis of Intravitreal Injectable
10.4 Industry Chain Structure of Intravitreal Injectable
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravitreal Injectable Distributors
11.3 Intravitreal Injectable Customer
12 WORLD FORECAST REVIEW FOR INTRAVITREAL INJECTABLE BY GEOGRAPHIC REGION
12.1 Global Intravitreal Injectable Market Size Forecast by Region
12.1.1 Global Intravitreal Injectable Forecast by Region (2025-2030)
12.1.2 Global Intravitreal Injectable Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravitreal Injectable Forecast by Drug
12.7 Global Intravitreal Injectable Forecast by Disease
13 KEY PLAYERS ANALYSIS
13.1 Regeneron Pharmaceuticals (Eylea)
13.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
13.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolios and Specifications
13.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview
13.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Intravitreal Injectable Product Portfolios and Specifications
13.2.3 Allergan Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 EyePoint Pharmaceuticals
13.3.1 EyePoint Pharmaceuticals Company Information
13.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolios and Specifications
13.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 EyePoint Pharmaceuticals Main Business Overview
13.3.5 EyePoint Pharmaceuticals Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Intravitreal Injectable Product Portfolios and Specifications
13.4.3 Genentech Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Kanghong Pharmaceutical
13.5.1 Kanghong Pharmaceutical Company Information
13.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolios and Specifications
13.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Kanghong Pharmaceutical Main Business Overview
13.5.5 Kanghong Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intravitreal Injectable Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Intravitreal Injectable Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Anti-VEGF
Table 4. Major Players of Steroids
Table 5. Major Players of Others
Table 6. Global Intravitreal Injectable Sales by Drug (2019-2024) & (K Units)
Table 7. Global Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Table 8. Global Intravitreal Injectable Revenue by Drug (2019-2024) & ($ million)
Table 9. Global Intravitreal Injectable Revenue Market Share by Drug (2019-2024)
Table 10. Global Intravitreal Injectable Sale Price by Drug (2019-2024) & (US$/Unit)
Table 11. Global Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 12. Global Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Table 13. Global Intravitreal Injectable Revenue by Disease (2019-2024)
Table 14. Global Intravitreal Injectable Revenue Market Share by Disease (2019-2024)
Table 15. Global Intravitreal Injectable Sale Price by Disease (2019-2024) & (US$/Unit)
Table 16. Global Intravitreal Injectable Sales by Company (2019-2024) & (K Units)
Table 17. Global Intravitreal Injectable Sales Market Share by Company (2019-2024)
Table 18. Global Intravitreal Injectable Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Intravitreal Injectable Revenue Market Share by Company (2019-2024)
Table 20. Global Intravitreal Injectable Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Intravitreal Injectable Producing Area Distribution and Sales Area
Table 22. Players Intravitreal Injectable Products Offered
Table 23. Intravitreal Injectable Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Intravitreal Injectable Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Intravitreal Injectable Sales Market Share Geographic Region (2019-2024)
Table 28. Global Intravitreal Injectable Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Intravitreal Injectable Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Intravitreal Injectable Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Intravitreal Injectable Sales Market Share by Country/Region (2019-2024)
Table 32. Global Intravitreal Injectable Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Intravitreal Injectable Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Intravitreal Injectable Sales by Country (2019-2024) & (K Units)
Table 35. Americas Intravitreal Injectable Sales Market Share by Country (2019-2024)
Table 36. Americas Intravitreal Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Intravitreal Injectable Revenue Market Share by Country (2019-2024)
Table 38. Americas Intravitreal Injectable Sales by Type (2019-2024) & (K Units)
Table 39. Americas Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 40. APAC Intravitreal Injectable Sales by Region (2019-2024) & (K Units)
Table 41. APAC Intravitreal Injectable Sales Market Share by Region (2019-2024)
Table 42. APAC Intravitreal Injectable Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Intravitreal Injectable Revenue Market Share by Region (2019-2024)
Table 44. APAC Intravitreal Injectable Sales by Drug (2019-2024) & (K Units)
Table 45. APAC Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 46. Europe Intravitreal Injectable Sales by Country (2019-2024) & (K Units)
Table 47. Europe Intravitreal Injectable Sales Market Share by Country (2019-2024)
Table 48. Europe Intravitreal Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Intravitreal Injectable Revenue Market Share by Country (2019-2024)
Table 50. Europe Intravitreal Injectable Sales by Type (2019-2024) & (K Units)
Table 51. Europe Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 52. Middle East & Africa Intravitreal Injectable Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Intravitreal Injectable Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Intravitreal Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Intravitreal Injectable Sales by Drug (2019-2024) & (K Units)
Table 57. Middle East & Africa Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Intravitreal Injectable
Table 59. Key Market Challenges & Risks of Intravitreal Injectable
Table 60. Key Industry Trends of Intravitreal Injectable
Table 61. Intravitreal Injectable Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Intravitreal Injectable Distributors List
Table 64. Intravitreal Injectable Customer List
Table 65. Global Intravitreal Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Intravitreal Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Intravitreal Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Intravitreal Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Intravitreal Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Intravitreal Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Intravitreal Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Intravitreal Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Intravitreal Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Intravitreal Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Intravitreal Injectable Sales Forecast by Drug (2025-2030) & (K Units)
Table 76. Global Intravitreal Injectable Revenue Forecast by Drug (2025-2030) & ($ Millions)
Table 77. Global Intravitreal Injectable Sales Forecast by Disease (2025-2030) & (K Units)
Table 78. Global Intravitreal Injectable Revenue Forecast by Disease (2025-2030) & ($ Millions)
Table 79. Regeneron Pharmaceuticals (Eylea) Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 80. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolios and Specifications
Table 81. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Regeneron Pharmaceuticals (Eylea) Main Business
Table 83. Regeneron Pharmaceuticals (Eylea) Latest Developments
Table 84. Allergan Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 85. Allergan Intravitreal Injectable Product Portfolios and Specifications
Table 86. Allergan Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Allergan Main Business
Table 88. Allergan Latest Developments
Table 89. EyePoint Pharmaceuticals Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 90. EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolios and Specifications
Table 91. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. EyePoint Pharmaceuticals Main Business
Table 93. EyePoint Pharmaceuticals Latest Developments
Table 94. Genentech Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 95. Genentech Intravitreal Injectable Product Portfolios and Specifications
Table 96. Genentech Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Genentech Main Business
Table 98. Genentech Latest Developments
Table 99. Kanghong Pharmaceutical Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 100. Kanghong Pharmaceutical Intravitreal Injectable Product Portfolios and Specifications
Table 101. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Kanghong Pharmaceutical Main Business
Table 103. Kanghong Pharmaceutical Latest Developments
Table 1. Intravitreal Injectable Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Intravitreal Injectable Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Anti-VEGF
Table 4. Major Players of Steroids
Table 5. Major Players of Others
Table 6. Global Intravitreal Injectable Sales by Drug (2019-2024) & (K Units)
Table 7. Global Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Table 8. Global Intravitreal Injectable Revenue by Drug (2019-2024) & ($ million)
Table 9. Global Intravitreal Injectable Revenue Market Share by Drug (2019-2024)
Table 10. Global Intravitreal Injectable Sale Price by Drug (2019-2024) & (US$/Unit)
Table 11. Global Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 12. Global Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Table 13. Global Intravitreal Injectable Revenue by Disease (2019-2024)
Table 14. Global Intravitreal Injectable Revenue Market Share by Disease (2019-2024)
Table 15. Global Intravitreal Injectable Sale Price by Disease (2019-2024) & (US$/Unit)
Table 16. Global Intravitreal Injectable Sales by Company (2019-2024) & (K Units)
Table 17. Global Intravitreal Injectable Sales Market Share by Company (2019-2024)
Table 18. Global Intravitreal Injectable Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Intravitreal Injectable Revenue Market Share by Company (2019-2024)
Table 20. Global Intravitreal Injectable Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Intravitreal Injectable Producing Area Distribution and Sales Area
Table 22. Players Intravitreal Injectable Products Offered
Table 23. Intravitreal Injectable Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Intravitreal Injectable Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Intravitreal Injectable Sales Market Share Geographic Region (2019-2024)
Table 28. Global Intravitreal Injectable Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Intravitreal Injectable Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Intravitreal Injectable Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Intravitreal Injectable Sales Market Share by Country/Region (2019-2024)
Table 32. Global Intravitreal Injectable Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Intravitreal Injectable Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Intravitreal Injectable Sales by Country (2019-2024) & (K Units)
Table 35. Americas Intravitreal Injectable Sales Market Share by Country (2019-2024)
Table 36. Americas Intravitreal Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Intravitreal Injectable Revenue Market Share by Country (2019-2024)
Table 38. Americas Intravitreal Injectable Sales by Type (2019-2024) & (K Units)
Table 39. Americas Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 40. APAC Intravitreal Injectable Sales by Region (2019-2024) & (K Units)
Table 41. APAC Intravitreal Injectable Sales Market Share by Region (2019-2024)
Table 42. APAC Intravitreal Injectable Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Intravitreal Injectable Revenue Market Share by Region (2019-2024)
Table 44. APAC Intravitreal Injectable Sales by Drug (2019-2024) & (K Units)
Table 45. APAC Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 46. Europe Intravitreal Injectable Sales by Country (2019-2024) & (K Units)
Table 47. Europe Intravitreal Injectable Sales Market Share by Country (2019-2024)
Table 48. Europe Intravitreal Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Intravitreal Injectable Revenue Market Share by Country (2019-2024)
Table 50. Europe Intravitreal Injectable Sales by Type (2019-2024) & (K Units)
Table 51. Europe Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 52. Middle East & Africa Intravitreal Injectable Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Intravitreal Injectable Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Intravitreal Injectable Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Intravitreal Injectable Sales by Drug (2019-2024) & (K Units)
Table 57. Middle East & Africa Intravitreal Injectable Sales by Disease (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Intravitreal Injectable
Table 59. Key Market Challenges & Risks of Intravitreal Injectable
Table 60. Key Industry Trends of Intravitreal Injectable
Table 61. Intravitreal Injectable Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Intravitreal Injectable Distributors List
Table 64. Intravitreal Injectable Customer List
Table 65. Global Intravitreal Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Intravitreal Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Intravitreal Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Intravitreal Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Intravitreal Injectable Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Intravitreal Injectable Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Intravitreal Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Intravitreal Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Intravitreal Injectable Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Intravitreal Injectable Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Intravitreal Injectable Sales Forecast by Drug (2025-2030) & (K Units)
Table 76. Global Intravitreal Injectable Revenue Forecast by Drug (2025-2030) & ($ Millions)
Table 77. Global Intravitreal Injectable Sales Forecast by Disease (2025-2030) & (K Units)
Table 78. Global Intravitreal Injectable Revenue Forecast by Disease (2025-2030) & ($ Millions)
Table 79. Regeneron Pharmaceuticals (Eylea) Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 80. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolios and Specifications
Table 81. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Regeneron Pharmaceuticals (Eylea) Main Business
Table 83. Regeneron Pharmaceuticals (Eylea) Latest Developments
Table 84. Allergan Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 85. Allergan Intravitreal Injectable Product Portfolios and Specifications
Table 86. Allergan Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Allergan Main Business
Table 88. Allergan Latest Developments
Table 89. EyePoint Pharmaceuticals Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 90. EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolios and Specifications
Table 91. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. EyePoint Pharmaceuticals Main Business
Table 93. EyePoint Pharmaceuticals Latest Developments
Table 94. Genentech Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 95. Genentech Intravitreal Injectable Product Portfolios and Specifications
Table 96. Genentech Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Genentech Main Business
Table 98. Genentech Latest Developments
Table 99. Kanghong Pharmaceutical Basic Information, Intravitreal Injectable Manufacturing Base, Sales Area and Its Competitors
Table 100. Kanghong Pharmaceutical Intravitreal Injectable Product Portfolios and Specifications
Table 101. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Kanghong Pharmaceutical Main Business
Table 103. Kanghong Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intravitreal Injectable
Figure 2. Intravitreal Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravitreal Injectable Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Intravitreal Injectable Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Intravitreal Injectable Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Anti-VEGF
Figure 10. Product Picture of Steroids
Figure 11. Product Picture of Others
Figure 12. Global Intravitreal Injectable Sales Market Share by Drug in 2023
Figure 13. Global Intravitreal Injectable Revenue Market Share by Drug (2019-2024)
Figure 14. Intravitreal Injectable Consumed in Macular Degeneration
Figure 15. Global Intravitreal Injectable Market: Macular Degeneration (2019-2024) & (K Units)
Figure 16. Intravitreal Injectable Consumed in Macular Edema
Figure 17. Global Intravitreal Injectable Market: Macular Edema (2019-2024) & (K Units)
Figure 18. Intravitreal Injectable Consumed in Uveitis
Figure 19. Global Intravitreal Injectable Market: Uveitis (2019-2024) & (K Units)
Figure 20. Intravitreal Injectable Consumed in Retinal Vein Occlusion
Figure 21. Global Intravitreal Injectable Market: Retinal Vein Occlusion (2019-2024) & (K Units)
Figure 22. Intravitreal Injectable Consumed in Others
Figure 23. Global Intravitreal Injectable Market: Others (2019-2024) & (K Units)
Figure 24. Global Intravitreal Injectable Sales Market Share by Disease (2023)
Figure 25. Global Intravitreal Injectable Revenue Market Share by Disease in 2023
Figure 26. Intravitreal Injectable Sales Market by Company in 2023 (K Units)
Figure 27. Global Intravitreal Injectable Sales Market Share by Company in 2023
Figure 28. Intravitreal Injectable Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Intravitreal Injectable Revenue Market Share by Company in 2023
Figure 30. Global Intravitreal Injectable Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Intravitreal Injectable Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Intravitreal Injectable Sales 2019-2024 (K Units)
Figure 33. Americas Intravitreal Injectable Revenue 2019-2024 ($ Millions)
Figure 34. APAC Intravitreal Injectable Sales 2019-2024 (K Units)
Figure 35. APAC Intravitreal Injectable Revenue 2019-2024 ($ Millions)
Figure 36. Europe Intravitreal Injectable Sales 2019-2024 (K Units)
Figure 37. Europe Intravitreal Injectable Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Intravitreal Injectable Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Intravitreal Injectable Revenue 2019-2024 ($ Millions)
Figure 40. Americas Intravitreal Injectable Sales Market Share by Country in 2023
Figure 41. Americas Intravitreal Injectable Revenue Market Share by Country in 2023
Figure 42. Americas Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Figure 43. Americas Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Figure 44. United States Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Intravitreal Injectable Sales Market Share by Region in 2023
Figure 49. APAC Intravitreal Injectable Revenue Market Share by Regions in 2023
Figure 50. APAC Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Figure 51. APAC Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Figure 52. China Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Intravitreal Injectable Sales Market Share by Country in 2023
Figure 60. Europe Intravitreal Injectable Revenue Market Share by Country in 2023
Figure 61. Europe Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Figure 62. Europe Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Figure 63. Germany Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Intravitreal Injectable Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Figure 71. Middle East & Africa Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Figure 72. Egypt Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Intravitreal Injectable in 2023
Figure 78. Manufacturing Process Analysis of Intravitreal Injectable
Figure 79. Industry Chain Structure of Intravitreal Injectable
Figure 80. Channels of Distribution
Figure 81. Global Intravitreal Injectable Sales Market Forecast by Region (2025-2030)
Figure 82. Global Intravitreal Injectable Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Intravitreal Injectable Sales Market Share Forecast by Drug (2025-2030)
Figure 84. Global Intravitreal Injectable Revenue Market Share Forecast by Drug (2025-2030)
Figure 85. Global Intravitreal Injectable Sales Market Share Forecast by Disease (2025-2030)
Figure 86. Global Intravitreal Injectable Revenue Market Share Forecast by Disease (2025-2030)
Figure 1. Picture of Intravitreal Injectable
Figure 2. Intravitreal Injectable Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravitreal Injectable Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Intravitreal Injectable Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Intravitreal Injectable Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Anti-VEGF
Figure 10. Product Picture of Steroids
Figure 11. Product Picture of Others
Figure 12. Global Intravitreal Injectable Sales Market Share by Drug in 2023
Figure 13. Global Intravitreal Injectable Revenue Market Share by Drug (2019-2024)
Figure 14. Intravitreal Injectable Consumed in Macular Degeneration
Figure 15. Global Intravitreal Injectable Market: Macular Degeneration (2019-2024) & (K Units)
Figure 16. Intravitreal Injectable Consumed in Macular Edema
Figure 17. Global Intravitreal Injectable Market: Macular Edema (2019-2024) & (K Units)
Figure 18. Intravitreal Injectable Consumed in Uveitis
Figure 19. Global Intravitreal Injectable Market: Uveitis (2019-2024) & (K Units)
Figure 20. Intravitreal Injectable Consumed in Retinal Vein Occlusion
Figure 21. Global Intravitreal Injectable Market: Retinal Vein Occlusion (2019-2024) & (K Units)
Figure 22. Intravitreal Injectable Consumed in Others
Figure 23. Global Intravitreal Injectable Market: Others (2019-2024) & (K Units)
Figure 24. Global Intravitreal Injectable Sales Market Share by Disease (2023)
Figure 25. Global Intravitreal Injectable Revenue Market Share by Disease in 2023
Figure 26. Intravitreal Injectable Sales Market by Company in 2023 (K Units)
Figure 27. Global Intravitreal Injectable Sales Market Share by Company in 2023
Figure 28. Intravitreal Injectable Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Intravitreal Injectable Revenue Market Share by Company in 2023
Figure 30. Global Intravitreal Injectable Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Intravitreal Injectable Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Intravitreal Injectable Sales 2019-2024 (K Units)
Figure 33. Americas Intravitreal Injectable Revenue 2019-2024 ($ Millions)
Figure 34. APAC Intravitreal Injectable Sales 2019-2024 (K Units)
Figure 35. APAC Intravitreal Injectable Revenue 2019-2024 ($ Millions)
Figure 36. Europe Intravitreal Injectable Sales 2019-2024 (K Units)
Figure 37. Europe Intravitreal Injectable Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Intravitreal Injectable Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Intravitreal Injectable Revenue 2019-2024 ($ Millions)
Figure 40. Americas Intravitreal Injectable Sales Market Share by Country in 2023
Figure 41. Americas Intravitreal Injectable Revenue Market Share by Country in 2023
Figure 42. Americas Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Figure 43. Americas Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Figure 44. United States Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Intravitreal Injectable Sales Market Share by Region in 2023
Figure 49. APAC Intravitreal Injectable Revenue Market Share by Regions in 2023
Figure 50. APAC Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Figure 51. APAC Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Figure 52. China Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Intravitreal Injectable Sales Market Share by Country in 2023
Figure 60. Europe Intravitreal Injectable Revenue Market Share by Country in 2023
Figure 61. Europe Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Figure 62. Europe Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Figure 63. Germany Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Intravitreal Injectable Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Intravitreal Injectable Sales Market Share by Drug (2019-2024)
Figure 71. Middle East & Africa Intravitreal Injectable Sales Market Share by Disease (2019-2024)
Figure 72. Egypt Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Intravitreal Injectable Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Intravitreal Injectable in 2023
Figure 78. Manufacturing Process Analysis of Intravitreal Injectable
Figure 79. Industry Chain Structure of Intravitreal Injectable
Figure 80. Channels of Distribution
Figure 81. Global Intravitreal Injectable Sales Market Forecast by Region (2025-2030)
Figure 82. Global Intravitreal Injectable Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Intravitreal Injectable Sales Market Share Forecast by Drug (2025-2030)
Figure 84. Global Intravitreal Injectable Revenue Market Share Forecast by Drug (2025-2030)
Figure 85. Global Intravitreal Injectable Sales Market Share Forecast by Disease (2025-2030)
Figure 86. Global Intravitreal Injectable Revenue Market Share Forecast by Disease (2025-2030)
